These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21073352)

  • 21. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
    Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon DS; Mullick WJ; Pettinato G; Schnitt SJ; Bianco AR; Ciardiello F
    Int J Cancer; 1996 Jan; 65(1):51-6. PubMed ID: 8543395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro.
    Focà G; Iaccarino E; Focà A; Sanguigno L; Untiveros G; Cuevas-Nunez M; Strizzi L; Leonardi A; Ruvo M; Sandomenico A
    Biochimie; 2019 Mar; 158():246-256. PubMed ID: 30703478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of different Cripto-1 antibodies and their variable results.
    Gudbergsson JM; Duroux M
    J Cell Biochem; 2020 Jan; 121(1):545-556. PubMed ID: 31310365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.
    Strizzi L; Postovit LM; Margaryan NV; Seftor EA; Abbott DE; Seftor RE; Salomon DS; Hendrix MJ
    Breast Dis; 2008; 29():91-103. PubMed ID: 19029628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
    Ciardiello F; Tortora G; Bianco C; Selvam MP; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico MG
    Oncogene; 1994 Jan; 9(1):291-8. PubMed ID: 8302592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
    Kenney NJ; Adkins HB; Sanicola M
    J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.
    Kelly RK; Olson DL; Sun Y; Wen D; Wortham KA; Antognetti G; Cheung AE; Orozco OE; Yang L; Bailly V; Sanicola M
    Eur J Cancer; 2011 Jul; 47(11):1736-46. PubMed ID: 21458984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
    Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
    Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
    Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.
    Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A
    Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
    Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
    Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
    Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M
    Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.
    Minchiotti G; Parisi S; Liguori G; Signore M; Lania G; Adamson ED; Lago CT; Persico MG
    Mech Dev; 2000 Feb; 90(2):133-42. PubMed ID: 10640699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
    Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.
    Ruggiero D; Nappo S; Nutile T; Sorice R; Talotta F; Giorgio E; Bellenguez C; Leutenegger AL; Liguori GL; Ciullo M
    PLoS Genet; 2015 Jan; 11(1):e1004976. PubMed ID: 25629528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21.
    Saccone S; Rapisarda A; Motta S; Dono R; Persico GM; Della Valle G
    Hum Genet; 1995 Feb; 95(2):229-30. PubMed ID: 7860072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The murine cripto gene: expression during mesoderm induction and early heart morphogenesis.
    Dono R; Scalera L; Pacifico F; Acampora D; Persico MG; Simeone A
    Development; 1993 Aug; 118(4):1157-68. PubMed ID: 7916676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.